Brief: Glenmark Pharmaceuticals And Cosmo Announce Signing Of Distribution And License Agreements For Winlevi In Europe, South Africa
Sept 27 (Reuters) - Glenmark Pharmaceuticals Ltd
GLEN.NS :
* ANNOUNCE SIGNING OF DISTRIBUTION AND LICENSE AGREEMENTS
FOR
WINLEVI IN EUROPE AND SOUTH AFRICA WITH COSMO
* CASSIOPEA TO GET UPFRONT PAYMENT OF $5 MILLION, FURTHER
DOUBLE-DIGIT REGULATORY AND SALES MILESTONES, AMONG OTHERS
Source text for Eikon: ID:nBSE5jCTPV
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cosmo NV
See all newsFocus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
Ireland's Cosmo recurring revenue rises on winlevi growth, reaffirms FY guidance
Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
Europe Research Roundup: Airbus ,Bechtle, Salzgitter